Researchers develop automated detection technique for eye surface cancer

A team of researchers from the Centre for Nanoscale BioPhotonics (CNBP) in Australia has developed a new automated non-i...

April 3, 2019 | Wednesday | News
Kazia to present on Cantrixil at AACR 2019 Annual Meeting

Australian oncology-focused biotech company Kazia Therapeutics Ltd has been selected to present data from the Phase I st...

March 25, 2019 | Monday | News
60P launches malaria preventive medicine in Australia

60 Degrees Pharmaceuticals (60P) and its Australian distribution partner Biocelect Pty Ltd, began commercialising the ne...

March 22, 2019 | Friday | News
Vertex receives approval for CF drug in Australia

Vertex Pharmaceuticals Incorporated has announced that the Therapeutic Goods Administration (TGA) of Australia has grant...

March 20, 2019 | Wednesday | News
SpeeDx distribution network expands to the Middle East

SpeeDx has announced signing new partners Al Zahrawi Medical Supplies LLC for distribution of ResistancePlus®&n...

March 18, 2019 | Monday | News
IBM Research to use ML for detecting Alzheimer's

A research team led by Dr Ben Goudey at IBM Research – Australia is using machine learning (ML) to ident...

March 15, 2019 | Friday | News
Atos inks AUD 124M contract with WA Health

Atos, a global leader in digital transformation, has signed an AUD124 million (approx. EUR78.2 ...

March 13, 2019 | Wednesday | News
Medicines Australia honors talent in pharma sector

Medicines Australia recently recognised the extraordinary talent in the Australian Pharmaceutical sector workforce at th...

March 11, 2019 | Monday | News
Kezar Life Sciences to test a new drug formulation of KZR-616

Kezar Life Sciences, a  South San Francisco-based clinical-stage biotechnology company discovering and developing n...

March 7, 2019 | Thursday | News
Australian Govt to invest $200M for cancer medicines

The Australian Government is investing more than $200 million to list four new breakthrough cancer treatments on the Pha...

February 28, 2019 | Thursday | News
RespireRx Pharma to commercialise OSA drug in Australia, NZ

RespireRx Pharmaceuticals Inc., a leader in the research and development of cannabinoids for the treatment of sleep-rela...

February 20, 2019 | Wednesday | News
Minomic executes agreement with Cirrus Dx

Australia based diagnostic company, Minomic International Ltd has announced that the company has executed an agreement w...

February 19, 2019 | Tuesday | News
Invitrocue appoints Prof Arial Zeng Yi as Patient Derived Organoid Consultant

Invitrocue, a leading healthcare bio-analytic solutions provider, is pleased to announce the appointment of Professor Ar...

February 18, 2019 | Monday | News
Mayne Pharma launches anti-plaque psoriasis agent in US

Mayne Pharma Group Limited has announced the launch of LEXETTE™ (halobetasol propionate) Foam 0.05% in the United ...

February 14, 2019 | Thursday | News
Cartherics and panCELLa announce collaborative agreement for cell therapy

Cartherics and panCELLa have announced their collaboration to research, develop and commercialize products for the treat...

February 15, 2019 | Friday | News
SpeeDx submits RespiVirus assay for clinical approval

SpeeDx Pty. Ltd. has announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration ...

February 13, 2019 | Wednesday | News
Invitrocue creates Joint Venture with A*STAR scientist Dr Chen Qingfeng

Invitrocue, a leading healthcare bio-analytic solutions provider, is pleased to announce the establishment of InvivoCue,...

February 12, 2019 | Tuesday | News
“An efficient approach to clinical trial design will have the greatest impact”

The annual J.P. Morgan Healthcare Conference is the premier investor conference focused exclusively on companies definin...

February 6, 2019 | Wednesday | Opinion